WBR0943
| Author | PageAuthor::William J Gibson |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Pharmacology |
| Sub Category | SubCategory::Oncology, SubCategory::Renal |
| Prompt | [[Prompt::A 72-year-old man with end-stage Chronic Lymphocytic Leukemia is administered an experimental treatment with tumor-targeting T-cells. Approximately two weeks after receiving the injection, the patient develops a fever of 104 F with shaking and chills. Laboratory studies reveal a thousand-fold increase in IL6 along with the following:
Sodium: 140 mEq/L Potassium: 5.5 mm/L Phosphate: 5.0 mg/dL Calcium: 8.0 mg/dL Uric acid: 16.0 mg/dL (Normal 2.0 – 8.0) Lactic Acid: 5.0 mEq/L (Normal 0.7-2.1) Which of the following drugs should be avoided in this patient?]] |
| Answer A | AnswerA::Hydrochlorothiazide |
| Answer A Explanation | AnswerAExp:: |
| Answer B | AnswerB::Furosemide |
| Answer B Explanation | AnswerBExp:: |
| Answer C | AnswerC::Corticosteroids |
| Answer C Explanation | AnswerCExp:: |
| Answer D | AnswerD::Allopurinol |
| Answer D Explanation | AnswerDExp:: |
| Answer E | AnswerE::Acetazolamide |
| Answer E Explanation | AnswerEExp:: |
| Right Answer | RightAnswer:: |
| Explanation | [[Explanation:: Educational Objective: |
| Approved | Approved::No |
| Keyword | |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |